Agilis Pharmaceuticals Llp - Company Profile

It is a paper limited liability partnership based in Kandivali West, Maharashtra, India, established in 2022.
2022 Kandivali West, Maharashtra, India Under Process Of Striking Off
Last Updated:
Access Report
About Agilis Pharmaceuticals Llp

Agilis Pharmaceuticals Llp, a under process of striking off limited liability partnership, was established on 25 July 2022 in Kandivali West, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds LLPIN: ABB-8641. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Mitesh Jayantilal Doshi (Designated Partner), Ruchi Nimish Siria (Designated Partner). It is based at Off-136, Kesar Residency Chs Ltd, Sector 3, Near Charkop Market,, Kandivali West, Maharashtra, 400067.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABB-8641

  • Incorporation Date

    25 July 2022

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 3 Year, 7 Months
Company report

Agilis Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Agilis Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Agilis Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Mitesh Jayantilal Doshi Designated Partner 25 Jul 2022 Current
Ruchi Nimish Siria Designated Partner 25 Jul 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Agilis Pharmaceuticals Llp.

Enhance accessibility to Agilis Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Agilis Pharmaceuticals Llp revenue growth over time
Agilis Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Agilis Pharmaceuticals Llp?

Unlock access to Agilis Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Agilis Pharmaceuticals Llp?

Unlock and access historical data on people associated with Agilis Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Agilis Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agilis Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Agilis Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Agilis Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was completed.

  • Director Appointment

    The activity Mitesh Jayantilal Doshi was appointed as a Designated Partner was appointed as a Designated Partner on 25 Jul 2022 & has been associated with this company since 3 years 7 months . was completed.

  • Director Appointment

    Progress on Ruchi Nimish Siria was appointed as a Designated Partner was appointed as a Designated Partner on 25 Jul 2022 & has been associated with this company since 3 years 7 months . was documented.

  • LLP Incorporation

    The activity Agilis Pharmaceuticals Llp was registered on 25 Jul 2022 with Roc Mumbai & aged 3 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Agilis Pharmaceuticals Llp?

The LLPIN of Agilis Pharmaceuticals Llp is ABB-8641.

Where is Agilis Pharmaceuticals Llp headquartered?

Agilis Pharmaceuticals Llp is headquartered at Off-136, Kesar Residency Chs Ltd, Sector 3, Near Charkop Market,, Kandivali West, Maharashtra, 400067.

When was Agilis Pharmaceuticals Llp incorporated?

Agilis Pharmaceuticals Llp was incorporated on 25 July 2022.

Who are the current directors of Agilis Pharmaceuticals Llp?

The current directors of Agilis Pharmaceuticals Llp are

What is the primary industry of Agilis Pharmaceuticals Llp?

The primary industry of Agilis Pharmaceuticals Llp is Paper.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available